OGN
Organon & Co.
NYSE · Healthcare · Drug Manufacturers - General · US
$13.78
+0.04%Leverage
- Debt / equity
- 8.50x
- Net debt / equity
- 7.38x
- Debt / assets
- 0.65x
- Debt / EBITDA
- 6.55x
- Net debt / EBITDA
- 5.68x
Liquidity & coverage
- Current ratio
- 1.95x
- Quick ratio
- 1.44x
- Cash ratio
- 0.43x
- Interest coverage
- 2.53x
- EBITDA / interest
- 2.79x
- Working capital
- $2.5B
Cash & dividend
- FCF / debt
- 0.06x
- Cash flow / debt
- 0.09x
- Dividend per share
- $0.08
- Dividend yield
- 0.6%
- Dividend growth 1y
- -69.6%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026